Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
NICE appraisal fees to be introduced despite opposition
The charges have been confirmed just days after a new 5 year UK pricing deal was finalised between the Department of Health and Social Care (DHSC) and the industry representative body
Latest news
-
Brexit contributes to surge in generic drug prices
The letter also describes the state of the current pricing and reimbursement systems, which are operated by the Department of Health and Social Care (DHSC).
-
FDA takes aim at pharma’s biosimilar-delaying tactics
He has spoken out repeatedly against anti-competitive tactics and pricing practices - unprecedented among FDA Commissioners - and is now promising to back up his words with actions. ... Reference pricing is one of the measures being considered in
-
Beneluxa: the future of European market access?
Meanwhile, there are some major concerns for pharma, too: some stakeholder groups want to use the legislation to enforce complete transparency on drug pricing negotiations, something which the industry will resist ... in. That’s an element the industry
-
As May delays, industry warns again of ‘no-deal’ Brexit
regulation, cross border movement of goods, comparative pricing and intellectual property.”.
-
Better together when buying medicines? Taking stock of the BeNeLuxA initiative
On information sharing there is the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, although it is wider than just Europe. ... There is MEDEV too, an informal cooperation on the assessment, pricing and reimbursement of medicines in
More from news
Approximately 87 fully matching, plus 761 partially matching documents found.
Latest Intelligence
-
Combined immunotherapies – potential and pitfalls
Economics. Developers willing to take on the additional challenges of trialling a combination immunotherapy need to keep pricing in mind.
-
New models of NHS care – new models of pharma response?
The Accelerated Access Collaborative. Ewan Barbour, Market Access and Pricing Director, Merck, presented on its multiple sclerosis treatment Mavenclad being selected to be among the first designated Rapid Uptake products on
-
How industry platforms can help transform outcomes-based contracting in healthcare
Without them, systematic pricing pressures are likely to further commoditise products – harmful not only for life sciences companies, but also for the creation of new innovations that can improve patient care.
-
Comment: the new UK pricing deal – welcome news, but lessons to be learned
Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement. ... Leslie Galloway, chairman, EMIG. The deal is done. After undoubtedly tense negotiations, the heads of terms for the new Voluntary Scheme for
-
Deal Watch October 2018
The Health Secretary, Alex Azar, has promised more to come on “fixing” drug pricing and introducing transparency into drug prices, and in the present political climate that can only be good
More from intelligence
Approximately 16 fully matching, plus 145 partially matching documents found.
Latest appointments
-
BMS appoints new commercial leader, Davies joins Eisai and more
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
-
Claes Buxfeldt joins NDA
He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
-
Mereo BioPharma appoints head of patient access and commercial planning
In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.
-
W2O bolsters its commercialisation offering
Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Glaze has 25 years’ experience in the biopharmaceutical and life science sector with expertise in marketing, managed markets, pricing strategy and communications.
More from appointments
Approximately 2 fully matching, plus 28 partially matching documents found.
Latest from PMHub
-
PR-it
PR-it combines the power of a global community of high-calibre, seasoned public relations, digital and creative experts with a proprietary data-driven pricing model.
-
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today. ... Our tailored services include strategic market
-
Patients’willingness to pay
Considerations when developing an appropriate pricing strategy in self-pay markets. When launching a new product, it’s critical that pharma chooses the right pricing strategy to achieve the optimal balance ... In emerging markets, pricing is made more
-
Combination therapies in oncology: The benefits of integrated insights
Key Learning Objectives:. Delegates will:. Learn about the major themes, challenges and opportunities for marketing an oncology therapy in combination, including clinical trial design, pricing, sequencing and product attributes, amongst others.
-
How integrated insights supported a biologic launch strategy across multiple indications
Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their new
More from PMHub
Approximately 7 fully matching, plus 48 partially matching documents found.
Featured jobs
-
Medical (Scientific) Director
-
£120, 000 benefits
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Business Development Director – Health Education
-
excellent commission
- Principal Health Economist - North-West
-
Negotiable
-
Medical Writer
-
Salary TBC
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Account Manager- Healthcare Advertising
-
Negotiable
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Account Director
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
-
Business Director
-
Competitive Salary Offered
-
Systematic Reviewer - Oxford
-
Negotiable
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
PMHub
Atlantis Healthcare
Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
